These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 7443440

  • 1. [Comparative study of the effects of probucol, fenofibrate and clofibrate on liver ultrastructure in rats (author's transl)].
    Barnard SD, Molello JA, Caldwell WJ, Lebeau JE.
    Nouv Presse Med; 1980 Oct 30; 9(40):3005-7. PubMed ID: 7443440
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Pharmacology of fenofibrate (author's transl)].
    Kritchevsky D.
    Nouv Presse Med; 1980 Dec 22; 9(49):3769-73. PubMed ID: 7208345
    [Abstract] [Full Text] [Related]

  • 4. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat.
    Staels B, Van Tol A, Fruchart JC, Auwerx J.
    Isr J Med Sci; 1996 Jun 22; 32(6):490-8. PubMed ID: 8682657
    [Abstract] [Full Text] [Related]

  • 5. [Fenofibrate: animal toxicology in relation to side-effects in man (author's transl)].
    Blane GF, Pinaroli F.
    Nouv Presse Med; 1980 Dec 22; 9(49):3737-46. PubMed ID: 7208340
    [Abstract] [Full Text] [Related]

  • 6. Comparative study of four hypolipidaemic agents on the activity of drug-metabolizing enzymes in rat liver microsomes.
    Fournel S, Magdalou J, Batt AM, Siest G.
    Int J Clin Pharmacol Res; 1983 Dec 22; 3(6):431-6. PubMed ID: 6432712
    [Abstract] [Full Text] [Related]

  • 7. [Morphometric study of hepatic peroxisomes in hyperlipoproteinemic patients treated with fenofibrate].
    Gariot P, Pointel JP, Barrat E, Drouin P, Debry G.
    Biomed Pharmacother; 1984 Dec 22; 38(2):101-6. PubMed ID: 6743770
    [Abstract] [Full Text] [Related]

  • 8. [Comparative biochemical and ultrastructural study of the hepatic response induced in the rat by 2 hypolipemic agents: clofibrate and itanoxone].
    Gendre PM, Marcelon G, Delhon A, Lauressergues H, Fauran F.
    J Pharmacol; 1984 Dec 22; 15(2):209-22. PubMed ID: 6738078
    [Abstract] [Full Text] [Related]

  • 9. [How does fenofibrate exert its cholesterol-lowering effect? (author's transl)].
    Wülfert E.
    Nouv Presse Med; 1980 Dec 22; 9(49):3733-6. PubMed ID: 7208339
    [Abstract] [Full Text] [Related]

  • 10. [Influence of fenofibrate on blood platelet functions (author's transl)].
    Renaud S, Dumont E, Drouin P, Debry G.
    Nouv Presse Med; 1980 Dec 22; 9(49):3763-7. PubMed ID: 7208344
    [Abstract] [Full Text] [Related]

  • 11. [Triglyceride synthesis and oleic acid catabolism by hepatic microsomes and mitochondria in clofibrate or procetofen-treated rats].
    Clouet E, Paris R.
    Reprod Nutr Dev (1980); 1980 Dec 22; 20(3A):637-45. PubMed ID: 7349434
    [Abstract] [Full Text] [Related]

  • 12. Effects of selected hypolipidemic drugs on cell ultrastructure.
    Svoboda DJ, Azarnoff DL.
    Fed Proc; 1971 Dec 22; 30(3):841-7. PubMed ID: 5575296
    [No Abstract] [Full Text] [Related]

  • 13. Peroxisome enzyme modification and oxidative stress in rat by hypolipidemic and antiinflammatory drugs.
    Rivero A, Monreal JI, Gil MJ.
    Rev Esp Fisiol; 1994 Dec 22; 50(4):259-68. PubMed ID: 7754169
    [Abstract] [Full Text] [Related]

  • 14. The hypolipidaemic activity of aqueous Erica multiflora flowers extract in Triton WR-1339 induced hyperlipidaemic rats: a comparison with fenofibrate.
    Harnafi H, Bouanani Nel H, Aziz M, Serghini Caid H, Ghalim N, Amrani S.
    J Ethnopharmacol; 2007 Jan 03; 109(1):156-60. PubMed ID: 17092671
    [Abstract] [Full Text] [Related]

  • 15. [Fenofibrate: chemical development and differences with clofibrate (author's transl)].
    Boucherle A.
    Nouv Presse Med; 1980 Dec 22; 9(49):3721-3. PubMed ID: 7208336
    [Abstract] [Full Text] [Related]

  • 16. [Animal toxicity studies of probucol (author's transl)].
    Lebeau JE.
    Nouv Presse Med; 1980 Oct 30; 9(40):3001-4. PubMed ID: 7443439
    [Abstract] [Full Text] [Related]

  • 17. Effects of antihyperlipidemic agents on hepatic insulin sensitivity in perfused Goto-Kakizaki rat liver.
    Matsuura B, Kanno S, Minami H, Tsubouchi E, Iwai M, Matsui H, Horiike N, Onji M.
    J Gastroenterol; 2004 Oct 30; 39(4):339-45. PubMed ID: 15168245
    [Abstract] [Full Text] [Related]

  • 18. [Therapy effects of fenofibrate on alcoholic fatty liver and drug-induced fatty liver in rats].
    Yan M, Meng FL, Lu RJ, Jia XQ, Zhao XC.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Feb 30; 11(2):86-9. PubMed ID: 12648401
    [Abstract] [Full Text] [Related]

  • 19. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
    Moody DE, Reddy JK.
    Res Commun Chem Pathol Pharmacol; 1974 Nov 30; 9(3):501-10. PubMed ID: 4445568
    [No Abstract] [Full Text] [Related]

  • 20. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D.
    Toxic Rep Ser; 1995 Apr 30; 30():1-G5. PubMed ID: 12209194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.